Cargando…
Dasatinib is a potent enhancer for CAR T cell generation by CD3-targeted lentiviral vectors
CD3-targeted lentiviral vectors (CD3-LVs) mediate selective transduction of human T lymphocytes in vitro and in vivo while simultaneously activating the targeted cells. Previously, we have demonstrated that CD3-LV leads to downmodulation of the CD3:T cell receptor (TCR) complex. We therefore hypothe...
Autores principales: | Braun, Angela H., Frank, Annika M., Ho, Naphang, Buchholz, Christian J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9801082/ https://www.ncbi.nlm.nih.gov/pubmed/36620073 http://dx.doi.org/10.1016/j.omtm.2022.12.002 |
Ejemplares similares
-
Precision medicine: In vivo CAR therapy as a showcase for receptor-targeted vector platforms
por: Michels, Alexander, et al.
Publicado: (2022) -
Monitoring CAR T cell generation with a CD8-targeted lentiviral vector by single-cell transcriptomics
por: Charitidis, Filippos T., et al.
Publicado: (2021) -
Monitoring CAR T cell generation with a CD8-targeted lentiviral vector by single-cell transcriptomics
por: Charitidis, Filippos T., et al.
Publicado: (2022) -
Highly Efficient and Selective CAR-Gene Transfer Using CD4- and CD8-Targeted Lentiviral Vectors
por: Jamali, Arezoo, et al.
Publicado: (2019) -
Physiological lentiviral vectors for the generation of improved CAR-T cells
por: Tristán-Manzano, María, et al.
Publicado: (2022)